Getinge-EXCH receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Getinge AB (GETIb)
Track the Getinge share price today and view real-time GETIb share price data, including charts, technicals, and key financials. View the GETIb premarket stock price ahead of the market session or assess the after hours quote. Explore GETIb stock price movements, trading volume, and market activity across the ST exchange.
What Is the Getinge Stock Price Today?
The Getinge stock price today is 282.5.
What Is the Stock Symbol for Getinge?
The stock symbol for Getinge is ""GETIb.""
What Stock Exchange Does Getinge Trade On?
Getinge is listed and trades on the Stockholm stock exchange.
Is Getinge a Good Stock to Buy?
Determining whether Getinge or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GETIb quote. (ISIN: SE0000202624)
What Is the Getinge Stock Price Today?
The Getinge stock price today is 282.5.
What Is the Stock Symbol for Getinge?
The stock symbol for Getinge is ""GETIb.""
What Stock Exchange Does Getinge Trade On?
Getinge is listed and trades on the Stockholm stock exchange.
Is Getinge a Good Stock to Buy?
Determining whether Getinge or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GETIb quote. (ISIN: SE0000202624)
282.5
+3.5(+1.25%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
279.8
283.0
52 wk Range
175.9
283.0
Trading near 52-week High
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
279.8283.0
52 wk Range
175.9283.0
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
GETIb Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
272.9
Downside
-3.40%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in overbought territory
Getinge-EXCH receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Getinge-EXCH receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Getinge-EXCH receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Why is Getinge stock climbing today?- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
4 Buy
6 Hold
1 Sell
Ratings:
11 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 272.9
(-3.40% Downside)
Earnings
Latest Release
21/10/2026
EPS / Forecast
3.10 / 2.51
Revenue / Forecast
8.45B / 8.5B
Compare GETIb to Peers and Sector
Metrics to compare | GETIb | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGETIbPeersSector | |
|---|---|---|---|---|
P/E Ratio | 27.2x | 24.6x | −0.2x | |
PEG Ratio | 0.72 | 1.16 | 0.00 | |
Price/Book | 2.4x | 2.6x | 2.6x | |
Price / LTM Sales | 2.2x | 3.3x | 2.8x | |
Upside (Analyst Target) | −3.4% | 7.4% | 62.7% | |
Fair Value Upside | Unlock | 11.2% | 8.0% | Unlock |
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, advanced patient monitoring, ICU infrastructure equipment, and drainage solutions. In addition, the company provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, vascular and cardiothoracic surgery equipment, peripheral stenting, OEM solutions, and beating heart surgery equipment; and operating room equipment, anesthesia, advanced patient monitoring, and operating room integration solutions. Further, it offers pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices, and patient flow management; and low temperature sterilization, biocontainment in vaccine production, terminal sterilization, sterile isolation technology, cleaning and sterilization, aseptic transfer, and large-scale cultivation. Additionally, the company provides bioreactor preparation solution, bioprocess development and optimization, labware cleaning and sterilization, biocontainment, and vivarium. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Getinge (GETIb) Stock Price Today?
The Getinge stock price today is 282.5 SEK.
What Stock Exchange Does Getinge Trade On?
Getinge is listed and trades on the Stockholm Stock Exchange.
What Is the Stock Symbol for Getinge?
The stock symbol for Getinge is "GETIb."
Does Getinge Pay Dividends? What’s The Current Dividend Yield?
The Getinge dividend yield is 1.7%%.
What Is the Getinge Market Cap?
As of today, Getinge market cap is 76.94B SEK.
What Is Getinge's Earnings Per Share (TTM)?
The Getinge EPS (TTM) is 10.39.
When Is the Next Getinge Earnings Date?
Getinge will release its next earnings report on 26/01/2027.
From a Technical Analysis Perspective, Is GETIb a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Getinge Stock Split?
Getinge has split 4 times.
How Many Employees Does Getinge Have?
Getinge has 11847 employees.
What is the current trading status of Getinge (GETIb)?
As of 06/11/2026, Getinge (GETIb) is trading at a price of 282.5 SEK, with a previous close of 282.5 SEK. The stock has fluctuated within a day range of 279.8 SEK to 283.0 SEK, while its 52-week range spans from 175.9 SEK to 283.0 SEK.
What Is Getinge (GETIb) Price Target According to Analysts?
The average 12-month price target for Getinge is 272.9 SEK, with a high estimate of 320 SEK and a low estimate of 193 SEK. 4 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an -3.40% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.